| Released | Contributor | Author | Title | Pages | Price |
| 26-Dec-2009 | PriceTarget Research, Inc. |
N/A
| Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 26-Dec-2009 | Standard & Poor's Quantitative Report |
N/A
| Sucampo Phrmaceuticals'A' | 6 |
$25 |
| 24-Dec-2009 | Pechala's Reports | Lubomir Pechala | SUCAMPO PHARMACEUTICALS INC (SCMP=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 23-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 23-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Comprehensive Rating Report | 48 |
$99 |
| 23-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: SUCAMPO PHARMA -- SCMP | 1 |
$4 |
| 23-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: AKRX , AOB , AUXL , AVNR , DYAX , IPXL , SCLN , SCMP -- DRUGS | 3 |
$4 |
| 23-Dec-2009 | Zacks Investment Research Inc. |
N/A
| SUCAMPO PHARMAC (SCMP) Zacks Company Snapshot | 1 |
$10 |
| 21-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for SCMP | 13 |
$25 |
| 20-Dec-2009 | Wright Reports |
N/A
| Wright Industry Averages: Chemicals (North America) | 72 |
$169 |
0.51% Nasdaq 
0.23 (5.49%) 
Research Reports
